metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Further peer review failures
Información de la revista
Vol. 66. Núm. 10.
Páginas 1833 (octubre 2011)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 66. Núm. 10.
Páginas 1833 (octubre 2011)
LETTER TO THE EDITOR
Open Access
Further peer review failures
Visitas
539
Horacio RiveraI,II,
Autor para correspondencia
hrivera@cencar.udg.mx

Tel.: 52 33 3618-9410
I División de Genética, CIBO, Instituto Mexicano del Seguro Social, Guadalajara, México.
II Genética Humana, CUCS, Universidad de Guadalajara, Guadalajara, México.
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo

Although peer review has been used to maintain the quality of published research, it can be a “seriously flawed” process1 and might result in the publication of papers with errors. I refer here to the report2 of a de novo (2;16)(q36.3;p13.3) translocation that is associated with Rubinstein-Taybi syndrome (RTS). This report was published in Clinics and contains a cytogenetic mistake in the depicted karyotype. Although the translocation is correct (2;16), the chromosome 2 breakpoint is juxtaposed to the centromere and not at 2q36.3. Thus, the telocentric der (2) is composed of the whole 2q (including the centromere) and is presumably capped with the 16p telomere whereas the whole 2p is attached to 16p13.3. Therefore, the correct karyotype should be written as 46,XX,t(2;16)(p11.2;p13.3)dn. In addition, the assertion by Torres et al.2 that their “RTS patient is the third reported case with a de novo t(2;16)(q36.3;p13.3)” is groundless because only one RTS patient with this translocation has been reported.3 In a subsequent paper, Torres et al.4 have repeated the same cytogenetic error. These remarks further stress that even serious mistakes may be unnoticed during the peer and editorial review process.

REFERENCES
[1]
DP Newton .
Quality and peer review of research: an adjudicating role for editors.
Account Res, 17 (2010), pp. 130-145
[2]
LC Torres , ML Lopes Chauffaille , TP Delboni , TS Okay , M Carneiro-Sampaio , S Sugayama .
Rubinstein-Taybi syndrome: a female patient with a de novo reciprocal translocation t(2;16)(q36.3; p13.3) and dysgranulopoiesis.
[3]
F Petrij , JC Dorsman , HG Dauwerse , RH Giles , T Peeters , RC Hennekam , et al.
Rubinstein-Taybi syndrome caused by a de novo reciprocal translocation t(2;16)(q36.3;p13.3).
[4]
LC Torres , SM Sugayama , C Arslanian , MM Sales , M Carneiro-Sampaio .
Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome.

No potential conflict of interest was reported.

Copyright © 2011. CLINICS
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos